Mabaloxavir (Xofluza) is an anti influenza virus drug, and its core medication instructions include five key aspects: indications, usage and dosage, adverse reactions, use in special populations, and drug interactions. The following will provide a detailed explanation of each key point to help patients use the medication safely and effectively.

1. Indications and mechanisms of action

(1) Suitable for treating simple influenza in patients aged 12 and above.

(2) It exerts antiviral effects by inhibiting influenza virus cap dependent endonuclease.

2 Usage and dosage specifications

(1) For single oral administration, a recommended dose of 80mg is recommended for individuals weighing ≥ 80kg.

(2) It should be taken within 48 hours after the onset of symptoms for optimal therapeutic effect.

3 Common Adverse Reactions

(1) Gastrointestinal reactions: diarrhea (1.6%), nausea (1.4%), etc.

(2) Other reactions include bronchitis (2.7%), headache (1.2%), etc.

4. Medication for special populations

(1) Pregnant women: Animal experiments have shown embryonic toxicity, and it is necessary to weigh the pros and cons when using it.

(2) Children: The safety and efficacy of patients under 12 years old have not been established.

5 important precautions

(1) Drug resistance: Improper use may lead to the development of viral drug resistance.

(2) Interaction: Co administration with preparations containing multivalent cations will reduce absorption.